Showing results (471-480 of 519) with videos related to

Sort By:
Pageof 52
Scandinavian Journal of Gastroenterology|November 24, 1999
Leptin and its receptor in normal human gastric mucosa and in Helicobacter pylori-associated gastritisM Breidert, S Miehlke, A Glasow, et al.
Histopathology|January 1, 1996
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel diseaseS C Bischoff, J Wedemeyer, A Herrmann, et al.
World Journal of Gastroenterology|January 31, 2002
Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT typeA Morgner, S Miehlke, M Stolte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Is the polymerase chain reaction or cure of Helicobacter pylori infection of help in the differential diagnosis of early gastric mucosa-associated lymphatic tissue lymphoma?B Rudolph, E Bayerdörffer, M Ritter, et al.
Digestion|November 14, 1998
Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infectionS Miehlke, A Meining, N Lehn, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2015
Peripheral blood eosinophils and other non-invasive biomarkers can monitor treatment response in eosinophilic oesophagitisC Schlag, S Miehlke, A Heiseke, et al.
Gastroenterology|October 10, 1997
Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study GroupM Sackmann, A Morgner, B Rudolph, et al.
International Journal of Cancer|November 1, 1994
Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological typesM Blank, E Klussmann, S Krüger-Krasagakes, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2006
Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycinS Miehlke, K Hansky, W Schneider-Brachert, et al.
Digestive Diseases (Basel, Switzerland)|September 24, 2004
Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopyR Kiesslich, S Kanzler, M Vieth, et al.
Pageof 52